Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1/2

Journal of Leukocyte Biology

Volumn 96, Issue 2, 2014, Pages 295-303

  Chen, Pei Min ^a   Liu, Ko Jiunn ^b,c   Hsu, Pei Ju ^a   Wei, Chung Fan ^a   Bai, Chyi Huey ^d   Ho, Ling Jun ^a   Sytwu, Huey Kang ^e   Linju Yen, B ^a,f  

^a Institute of Cellular and System Medicine   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^f CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

Th1 2 cytokine

Indexed keywords

CD14 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE 3; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELLULAR SECRETION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SOMATIC CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

CD14+ CELLS; CD4+ T CELLS; TH1/2 CYTOKINE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-10; MALE; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MONOCYTES; PROTO-ONCOGENE PROTEINS C-MET; TH1 CELLS; TH2 CELLS;

EID: 84904993626     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3A0513-242R     Document Type: Article

References (45)

1. Rees, A. J. (2010) Monocyte and macrophage biology: an overview. Semin. Nephrol. 30, 216-233.
2. Gordon, S., Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
3. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., Marshak, D. R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
4. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., Horwitz, E. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317.
5. Friedenstein, A. J., Petrakova, K. V., Kurolesova, A. I., Frolova, G. P. (1968) Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6, 230-247.
6. Brooke, G., Cook, M., Blair, C., Han, R., Heazlewood, C., Jones, B., Kambouris, M., Kollar, K., McTaggart, S., Pelekanos, R., Rice, A., Rossetti, T., Atkinson, K. (2007) Therapeutic applications of mesenchymal stromal cells. Semin. Cell. Dev. Biol. 18, 846-858.
7. Hass, R., Kasper, C., Bohm, S., Jacobs, R. (2011) Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell. Commun. Signal 9, 12.
8. Yen, B. L., Huang, H. I., Chien, C. C., Jui, H. Y., Ko, B. S., Yao, M., Shun, C. T., Yen, M. L., Lee, M. C., Chen, Y. C. (2005) Isolation of multipotent cells from human term placenta. Stem Cells 23, 3-9.
9. Uccelli, A., Moretta, L., Pistoia, V. (2008) Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 8, 726-736.
10. Chen, P. M., Yen, M. L., Liu, K. J., Sytwu, H. K., Yen, B. L. (2011) Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J. Biomed. Sci. 18, 49-59.
11. Le Blanc, K., Ringden, O. (2007) Immunomodulation by mesenchymal stem cells and clinical experience. J. Intern. Med. 262, 509-525.
12. Nauta, A. J., Fibbe, W. E. (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110, 3499-3506.
13. Rasmusson, I. (2006) Immune modulation by mesenchymal stem cells. Exp. Cell. Res. 312, 2169-2179.
14. Cutler, A. J., Limbani, V., Girdlestone, J., Navarrete, C. V. (2010) Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation. J. Immunol. 185, 6617-6623.
15. Wu, C. C., Chao, Y. C., Chen, C. N., Chien, S., Chen, Y. C., Chien, C. C., Chiu, J. J., Linju Yen, B. (2008) Synergism of biochemical and mechanical stimuli in the differentiation of human placenta-derived multipotent cells into endothelial cells. J. Biomech. 41, 813-821.
16. Yen, B. L., Chien, C. C., Chen, Y. C., Chen, J. T., Huang, J. S., Lee, F. K., Huang, H. I. (2008) Placenta-derived multipotent cells differentiate into neuronal and glial cells in vitro. Tissue Eng. Part A 14, 9-17.
17. Huang, G. S., Dai, L. G., Yen, B. L., Hsu, S. H. (2011) Spheroid formation of mesenchymal stem cells on chitosan and chitosan-hyaluronan membranes. Biomaterials 32, 6929-6945.
18. Chang, C. J., Yen, M. L., Chen, Y. C., Chien, C. C., Huang, H. I., Bai, C. H., Yen, B. L. (2006) Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-β. Stem Cells 24, 2466-2477.
19. Liu, K. J., Wang, C. J., Chang, C. J., Hu, H. I., Hsu, P. J., Wu, Y. C., Bai, C. H., Sytwu, H. K., Yen, B. L. (2011) Surface expression of HLA-G is involved in mediating immunomodulatory effects of placenta-derived multipotent cells (PDMCs) towards natural killer lymphocytes. Cell. Transplant. 20, 1721-1730.
20. Yen, M. L., Chien, C. C., Chiu, I. M., Huang, H. I., Chen, Y. C., Hu, H. I., Yen, B. L. (2007) Multilineage differentiation and characterization of the human fetal osteoblastic 1. 19 cell line: a possible in vitro model of human mesenchymal progenitors. Stem Cells 25, 125-131.
21. Yen, B. L., Chang, C. J., Liu, K. J., Chen, Y. C., Hu, H. I., Bai, C. H., Yen, M. L. (2009) Human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes. Stem Cells 27, 451-456.
22. Chien, C. C., Yen, B. L., Lee, F. K., Lai, T. H., Chen, Y. C., Chan, S. H., Huang, H. I. (2006) In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells. Stem Cells 24, 1759-1768.
23. Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M., Kmiecik, T. E., Vande Woude, G. F., Aaronson, S. A. (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251, 802-804.
24. Skibinski, G., Skibinska, A., James, K. (2001) The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs. Immunology 102, 506-514.
25. Beilmann, M., Odenthal, M., Jung, W., Vande Woude, G. F., Dienes, H. P., Schirmacher, P. (1997) Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. Blood 90, 4450-4458.
26. Van Furth, R., Diesselhoff-den Dulk, M. C., Mattie, H. (1973) Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction. J. Exp. Med. 138, 1314-1330.
27. Auffray, C., Sieweke, M. H., Geissmann, F. (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27, 669-692.
28. Ziegler-Heitbrock, L., Ancuta, P., Crowe, S., Dalod, M., Grau, V., Hart, D. N., Leenen, P. J., Liu, Y. J., MacPherson, G., Randolph, G. J., Scherberich, J., Schmitz, J., Shortman, K., Sozzani, S., Strobl, H., Zembala, M., Austyn, J. M., Lutz, M. B. (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116, e74-e80.
29. Comoglio, P. M. (2001) Pathway specificity for Met signalling. Nat. Cell Biol. 3, E161-E162.
30. Saraiva, M., O'Garra, A. (2010) The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181.
31. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., Gianni, A. M. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838-3843.
32. Letterio, J. J., Roberts, A. B. (1998) Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16, 137-161.
33. Le Blanc, K., Rasmusson, I., Gotherstrom, C., Seidel, C., Sundberg, B., Sundin, M., Rosendahl, K., Tammik, C., Ringden, O. (2004) Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand. J. Immunol. 60, 307-315.
34. Bhargava, M., Joseph, A., Knesel, J., Halaban, R., Li, Y., Pang, S., Goldberg, I., Setter, E., Donovan, M. A., Zarnegar, R., Michalopoulos, G. A., Nakamura, T., Faletto, D., Rosen, E. M. (1992) Scatter factor and hepatocyte growth factor: activities, properties, and mechanism. Cell Growth Differ. 3, 11-20.
35. Trusolino, L., Bertotti, A., Comoglio, P. M. (2010) MET signalling: principles and functions in development, organ regeneration and cancer. Nat. Rev. Mol. Cell. Biol. 11, 834-848.
36. Futamatsu, H., Suzuki, J., Mizuno, S., Koga, N., Adachi, S., Kosuge, H., Maejima, Y., Hirao, K., Nakamura, T., Isobe, M. (2005) Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ. Res. 96, 823-830.
37. Okunishi, K., Dohi, M., Nakagome, K., Tanaka, R., Mizuno, S., Matsumoto, K., Miyazaki, J., Nakamura, T., Yamamoto, K. (2005) A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J. Immunol. 175, 4745-4753.
38. low/neg accessory cells with dendritic-cell features. Blood 108, 218-227.
39. Rabinovich, G. A., Gabrilovich, D., Sotomayor, E. M. (2007) Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25, 267-296.
40. Mantovani, A. (2012) MSCs, macrophages, and cancer: a dangerous menage-a-trois. Cell. Stem Cell 11, 730-732.
41. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., Mathison, J. C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433.
42. Winzler, C., Rovere, P., Zimmermann, V. S., Davoust, J., Rescigno, M., Citterio, S., Ricciardi-Castagnoli, P. (1997) Checkpoints and functional stages in DC maturation. Adv. Exp. Med. Biol. 417, 59-64.
43. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
44. Galimi, F., Cottone, E., Vigna, E., Arena, N., Boccaccio, C., Giordano, S., Naldini, L., Comoglio, P. M. (2001) Hepatocyte growth factor is a regulator of monocyte-macrophage function. J. Immunol. 166, 1241-1247.
45. Swirski, F. K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., Panizzi, P., Figueiredo, J. L., Kohler, R. H., Chudnovskiy, A., Waterman, P., Aikawa, E., Mempel, T. R., Libby, P., Weissleder, R., Pittet, M. J. (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325, 612-616.